These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 32998742)

  • 1. The additive effects of type 2 diabetes mellitus on left ventricular deformation and myocardial perfusion in essential hypertension: a 3.0 T cardiac magnetic resonance study.
    Li XM; Jiang L; Guo YK; Ren Y; Han PL; Peng LQ; Shi R; Yan WF; Yang ZG
    Cardiovasc Diabetol; 2020 Sep; 19(1):161. PubMed ID: 32998742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular subclinical myocardial dysfunction in uncomplicated type 2 diabetes mellitus is associated with impaired myocardial perfusion: a contrast-enhanced cardiovascular magnetic resonance study.
    Liu X; Yang ZG; Gao Y; Xie LJ; Jiang L; Hu BY; Diao KY; Shi K; Xu HY; Shen MT; Ren Y; Guo YK
    Cardiovasc Diabetol; 2018 Oct; 17(1):139. PubMed ID: 30373588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of type 2 diabetes mellitus on left ventricular diastolic function in patients with essential hypertension: evaluation by volume-time curve of cardiac magnetic resonance.
    Yan WF; Gao Y; Zhang Y; Guo YK; Wang J; Jiang L; Li Y; Yang ZG
    Cardiovasc Diabetol; 2021 Mar; 20(1):73. PubMed ID: 33766020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of pretransplant T2DM on left ventricular deformation and myocardial perfusion in heart transplanted recipients: a 3.0 T cardiac magnetic resonance study.
    Cao L; Liu C; Ou C; Ma Q; Xu H; Li X; Bao Y; Chen R; Yang Y; Wu M; Liu H
    Cardiovasc Diabetol; 2024 Jun; 23(1):216. PubMed ID: 38907259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive effect of metabolic dysfunction-associated fatty liver disease on left ventricular function and global strain in type 2 diabetes mellitus patients: a 3.0 T cardiac magnetic resonance feature tracking study.
    Tang X; Shi R; Jiang L; Yan WF; Han PL; Qian WL; Yang ZG; Li Y
    Cardiovasc Diabetol; 2024 Aug; 23(1):317. PubMed ID: 39192259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of T2DM on right ventricular systolic dysfunction and interventricular interactions in patients with essential hypertension: evaluation using CMR tissue tracking.
    Li XM; Yan WF; Jiang L; Shi K; Ren Y; Han PL; Peng LQ; Guo YK; Yang ZG
    Cardiovasc Diabetol; 2022 Nov; 21(1):238. PubMed ID: 36352469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The additive effects of obesity on myocardial microcirculation in diabetic individuals: a cardiac magnetic resonance first-pass perfusion study.
    Jiang L; Shi K; Guo YK; Ren Y; Li ZL; Xia CC; Li L; Liu X; Xie LJ; Gao Y; Shen MT; Deng MY; Yang ZG
    Cardiovasc Diabetol; 2020 May; 19(1):52. PubMed ID: 32375795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased fractal dimension of left ventricular trabeculations is associated with subclinical diastolic dysfunction in patients with type-2 diabetes mellitus.
    Shang Y; Zhang X; Leng W; Lei X; Chen L; Zhou X; Chow K; Shi Y; Dong J; Liang Z; Wang J
    Int J Cardiovasc Imaging; 2019 Apr; 35(4):665-673. PubMed ID: 30430327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The differential effects of dyslipidemia status and triglyceride-glucose index on left ventricular global function and myocardial microcirculation in diabetic individuals: a cardiac magnetic resonance study.
    Jiang L; Xu HY; Li Y; Shi K; Fang H; Yan WF; Guo YK; Yang ZG
    Cardiovasc Diabetol; 2024 Sep; 23(1):345. PubMed ID: 39300497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of subclinical LV myocardial dysfunction in T2DM patients with diabetic peripheral neuropathy: a cardiovascular magnetic resonance study.
    Li XM; Shi K; Jiang L; Wang J; Yan WF; Gao Y; Shen MT; Shi R; Zhang G; Liu XJ; Guo YK; Yang ZG
    Cardiovasc Diabetol; 2024 Jun; 23(1):217. PubMed ID: 38915040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The additive effects of kidney dysfunction on left ventricular function and strain in type 2 diabetes mellitus patients verified by cardiac magnetic resonance imaging.
    Zhang Y; Wang J; Ren Y; Yan WF; Jiang L; Li Y; Yang ZG
    Cardiovasc Diabetol; 2021 Jan; 20(1):11. PubMed ID: 33413395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of myocardial scars on left ventricular deformation in type 2 diabetes mellitus after myocardial infarction by contrast-enhanced cardiac magnetic resonance.
    Gao Y; Xu HY; Guo YK; Wen XL; Shi R; Li Y; Yang ZG
    Cardiovasc Diabetol; 2021 Oct; 20(1):215. PubMed ID: 34696783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection of left atrial and bi-ventricular myocardial strain abnormalities by MRI feature tracking in normotensive or hypertensive T2DM patients with preserved LV function.
    Shao G; Cao Y; Cui Y; Han X; Liu J; Li Y; Li N; Liu T; Yu J; Shi H
    BMC Cardiovasc Disord; 2020 Apr; 20(1):196. PubMed ID: 32326882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adverse impact of coronary artery disease on left ventricle systolic and diastolic function in patients with type 2 diabetes mellitus: a 3.0T CMR study.
    Wang J; Li Y; Guo YK; Huang S; Shi R; Yan WF; Qian WL; He GX; Yang ZG
    Cardiovasc Diabetol; 2022 Feb; 21(1):30. PubMed ID: 35193565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical left ventricular deformation and microvascular dysfunction in T2DM patients with and without peripheral neuropathy: assessed by 3.0 T cardiac magnetic resonance imaging.
    Li XM; Shi R; Shen MT; Yan WF; Jiang L; Min CY; Liu XJ; Guo YK; Yang ZG
    Cardiovasc Diabetol; 2023 Sep; 22(1):256. PubMed ID: 37735418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interdependence between myocardial deformation and perfusion in patients with T2DM and HFpEF: a feature-tracking and stress perfusion CMR study.
    Li XN; Liu YT; Kang S; Qu Yang DZ; Xiao HY; Ma WK; Shen CX; Pan JW
    Cardiovasc Diabetol; 2024 Aug; 23(1):303. PubMed ID: 39152461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of diabetes mellitus on left ventricular function and remodeling in hypertensive patients with heart failure with reduced ejection fraction: assessment with 3.0 T MRI feature tracking.
    Zhang G; Shi K; Yan WF; Li XM; Li Y; Guo YK; Yang ZG
    Cardiovasc Diabetol; 2022 May; 21(1):69. PubMed ID: 35524215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine.
    Chen WJY; Diamant M; de Boer K; Harms HJ; Robbers LFHJ; van Rossum AC; Kramer MHH; Lammertsma AA; Knaapen P
    Cardiovasc Diabetol; 2017 May; 16(1):67. PubMed ID: 28526033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional Impact of Aortic Regurgitation on Left Ventricular Strain and Remodeling in Essential Hypertension Patients Evaluated Using MRI.
    Yan WF; Yang ZG; Li XM; Tang SS; Guo YK; Jiang L; Min CY; Li Y
    J Magn Reson Imaging; 2024 Jul; 60(1):339-349. PubMed ID: 37966904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggravation of functional mitral regurgitation on left ventricle stiffness in type 2 diabetes mellitus patients evaluated by CMR tissue tracking.
    Zhang Y; Yan WF; Jiang L; Shen MT; Li Y; Huang S; Shi K; Yang ZG
    Cardiovasc Diabetol; 2021 Jul; 20(1):158. PubMed ID: 34332579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.